[1] HEINOLAINEN A,NGUYEN B,SILÉN S,et al.Survival and data-driven phenotypes in head and neck cancer[J].Sci Rep,2025,15(1):5985. [2] PUNOVUORI K,BERTILLOT F,MIROSHNIKOVA Y A,et al.Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer[J].Cell,2024,187(25):7267-7284.e20. [3] 冯阳光,杨东霖,李星慧,等.整合素受体在肾脏疾病中的作用及机制[J].肾脏病与透析肾移植杂志,2025,34(4):365-370. FENG Y G,YANG D L,LI X H,et al.The role and molecular mechanisms of integrin receptors in renal disorders[J].Chin J Nephrol Dial Transplant,2025,34(4):365-370. [4] 赵瑞,华清泉.整合素αvβ6在头颈部鳞状细胞癌中的作用研究[J].中国中西医结合耳鼻咽喉科杂志,2023,31(3):189-194,209. ZHAO R,HUA Q Q.The role of integrin αvβ6 in head and neck squamous cell carcinoma[J].Chin J Otorhinolaryngol Integr Med,2023,31(3):189-194,209. [5] ZOU C,ZHU J,XIONG J,et al.Comprehensive characterization of the integrin family across 32 cancer types[J].Genomics Proteomics Bioinformatics,2024,22(4):qzae035. [6] XU L,BARRETT J G,PENG J,et al.ITGAV promotes the progression of head and neck squamous cell carcinoma[J].Curr Oncol,2024,31(3):1311-1322. [7] KAMARAJAN P,ATEIA I,SHIN J M,et al.Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin[J].PLoS Pathog,2020,16(10):e1008881. [8] NAKAMURA T,SHINRIKI S,JONO H,et al.Osteopontin-integrin α(v)β(3)axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma[J].FEBS Lett,2015,589(2):231-239. [9] ROUTILA E,SALMINEN S,MAHRAN R,et al.Evaluation of integrin glycovariants as biomarkers of metastasis,invasion,and therapy stratification in head and neck squamous cell carcinoma[J].Cancer Med,2025,14(9):e70717. [10] QI X,ZHOU J,WANG P,et al.KLF7-regulated ITGA2 as a therapeutic target for inhibiting oral cancer stem cells[J].Cell Death Dis,2025,16(1):354. [11] LIU J,WANG Y,CHEN X,et al.ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma[J].Diagn Pathol,2024,19(1):134. [12] LI D P,SUN A J,ZHANG L,et al.Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2[J].Theranostics,2022,12(17):7431-7449. [13] RYU M H,PARK H M,CHUNG J,et al.Hypoxia-inducible factor-1 alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin[J].Biochem Biophys Res Commun,2010,393(1):11-15. [14] ZHAO X,MAI Z,LIU L,et al.Hypoxia-driven TNS4 fosters HNSCC tumorigenesis by stabilizing integrin α5β1 complex and triggering FAK-mediated Akt and TGFβ signaling pathways[J].Int J Biol Sci,2024,20(1):231-248. [15] ANGGRADITA L D,KIM J H,KIM M K,et al.Targeting the integrin beta 1-focal adhesion kinase axis with artemisinin:Biophysical disruption of cell adhesion,migration,and invasion in tongue cancer[J].VIEW,2025,6(2):20240089. [16] PARK S J,MIN H J,YOON C,et al.Integrin β1 regulates the perineural invasion and radioresistance of oral squamous carcinoma cells by modulating cancer cell stemness[J].Cell Signal,2023,110:110808. [17] KOROVINA I,ELSER M,BORODINS O,et al.β1 integrin mediates unresponsiveness to PI3Kα inhibition for radiochemosensitization of 3 D HNSCC models[J].Biomed Pharmacother,2024,171:116217. [18] JIANG W,CHEN L,LI R,et al.Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma:a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker[J].BMC Med,2024,22(1):314. [19] NGUYEN J,CHONG T W,ELMI H,et al.Role of hemidesmosomes in oral carcinogenesis:A systematic review[J].Cancers,2023,15(9):2533. [20] SCHINKE H,SHI E,LIN Z,et al.A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer[J].Mol Cancer,2022,21(1):178. [21] ZHOU J,HE M,ZHAO Q,et al.EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer[J].Mol Cancer,2025,24(1):94. [22] AGUDO J,AGUIRRE-GHISO J A,BHATIA M,et al.Targeting cancer cell dormancy[J].Nat Rev Cancer,2024,24(2):97-104. [23] PAN S,LIU H,XIAO H,et al.ITGB6 promotes tumor recurrence and metastasis by mediating the resistance of daughter cells of PGCCs to anoikis:ITGB6 promotes tumor recurrence and metastasis via Anoikis resistance[J].Sci Rep,2025,15(1):33571. [24] SAKURAI S,ISHIDA Y,SHINTANI T,et al.Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma:a retrospective observational study[J].Pathol Oncol Res,2024,30:1611571. [25] WANG S H,CHEN Y L,HUANG S H,et al.Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11 a-dependent glycolytic reprogramming[J].Oncogenesis,2025,14(1):6. [26] ZHANG X,DONG Y,ZHAO M,et al.ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system[J].Theranostics,2020,10(26):12044-12059. [27] ZHANG H R,QIAN Y M,ZHANG Y,et al.Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression[J].NPJ Precis Oncol,2024,8(1):272. [28] LI J,LI S,SHU M,et al.Unravelling the heterogeneity of oral squamous cell carcinoma by integrative analysis of single-cell and bulk transcriptome data[J].J Cell Mol Med,2024,28(3):e18108. [29] RAJTHALA S,MIN A,PARAJULI H,et al.Profiling and functional analysis of microRNA deregulation in cancer-associated fibroblasts in oral squamous cell carcinoma depicts an anti-invasive role of microRNA-204 via regulation of their motility[J].Int J Mol Sci,2021,22(21):11960. [30] LIU X,LI J,YANG X,et al.Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK/p-paxillin/YAP signaling[J].Int J Oral Sci,2023,15(1):32. [31] LI X,ZHAO H,JIANG E,et al.ITGB1/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1α degradation[J].Oncogene,2025,44(20):1530-1544. [32] WANG S H,LIOU G G,LIU S H,et al.Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin α3-dependent uptake by lymphatic endothelial cells[J].Int J Cancer,2019,144(11):2795-2810. [33] ISHIYAMA T,SANO D,TAKAHASHI H,et al.Ligand-receptor interactions between squamous and endothelial cells induce head and neck squamous cell carcinoma[J].Cancer Sci,2025,116(8):2296-2305. [34] YOU B,PAN S,GU M,et al.Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation[J].J Extracell Vesicles,2022,11(5):e12221. [35] 徐潇奕,王斌,杨檬檬,等.肿瘤相关的巨噬细胞在口腔癌中的促癌机制[J].中国肿瘤临床,2025,52(15):783-790. XU X Y,WANG B,YANG M M,et al.Pro-tumorigenic mechanisms of tumor-associated macrophages in oral cancer[J].Chin J Clin Oncol,2025,52(15):783-790. [36] ZHANG C,LI K,ZHU H,et al.ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration[J].Nat Commun,2024,15(1):7077. [37] GUO C,SUN H,DU Y,et al.Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization[J].J Exp Clin Cancer Res,2025,44(1):1. [38] EKSTEDT S,CARDENAS E I,PIERSIALA K,et al.CD18 and CD36 expression in neutrophils from tumors and tumor-draining lymph nodes:Implications for metastasis in oral squamous cell carcinoma[J].Clin Exp Metastasis,2025,42(4):37. |